Search
Search Results
-
Updates in Management of Malignant Pleural Mesothelioma
Malignant pleural mesothelioma (MPM) is an aggressive asbestos-associated thoracic malignancy that is usually incurable. As demonstrated in the...
-
Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors
Malignant pleural mesothelioma (MPM) is a rare and challenging cancer associated with asbestos fiber exposure, which offers limited treatment...
-
Malignant Sarcomatoid Pleural Mesothelioma Presenting as a Chest Wall Tumor
Malignant mesothelioma is a rare and aggressive neoplasm with a median survival of less than 12 months and a 5-year survival rate of less than 5%....
-
Optimal surgery for resectable malignant pleural mesothelioma in the setting of multimodality treatment
The surgical treatment of malignant pleural mesothelioma (MPM) involves procedures to achieve macroscopic complete resection, depending on the...
-
The Evolving Therapeutic Landscape for Malignant Pleural Mesothelioma
Purpose of ReviewFor patients with malignant pleural mesothelioma, prognosis is poor with extremely low 5-year survival rates and limited therapeutic...
-
Treatment patterns and humanistic burden of malignant pleural mesothelioma in Spain
PurposeMalignant pleural mesothelioma (MPM) is an aggressive cancer with long latency and poor prognosis. The real-world treatment patterns and...
-
Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP
Malignant pleural mesothelioma is a rare and aggressive neoplasm, which has primarily been attributed to the exposure to asbestos fibers (83% of...
-
Sarcomatoid malignant pleural mesothelioma: a case of long-term recurrence-free survival following curative intent surgery alone
BackgroundCurative intent surgery may be indicated for some patients with resectable early stage malignant pleural mesothelioma (MPM). However,...
-
Impact of Pleural Thickness on Occurrence of Postoperative Complications in Patients with Malignant Pleural Mesothelioma
ObjectivesThe rates of postoperative mortality and morbidity are high in patients with malignant pleural mesothelioma (MPM). Therefore, it is...
-
Genetic analysis of familial predisposition in the pathogenesis of malignant pleural mesothelioma
PurposeMesothelioma is the primary tumor of the mesothelial cell membrane. The most important etiology is asbestos exposure. The development of...
-
Safety and efficacy of helical tomotherapy following lung-sparing surgery in locally advanced malignant pleural mesothelioma
PurposeTo assess the value of radiation therapy (RT) with helical tomotherapy (HT) in the management of locally advanced malignant pleural...
-
Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma
BackgroundMalignant pleural mesothelioma (MPM) is a rare and usually fatal malignancy frequently linked to occupational asbestos exposures and...
-
Biphasic pleural mesothelioma treated successfully with multimodal therapy: a case report
BackgroundPleural mesothelioma is an aggressive malignant tumor and has a poor prognosis. In particular, biphasic pleural mesothelioma is a less...
-
Malignant Pleural Mesothelioma Advances in Pathogenesis, Diagnosis, and Treatments
This book provides essential information on recent advances in molecular genetics, epidemiology, translational research, and the latest results of...
-
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Purpose of ReviewIn this article, we provide a comprehensive analysis of recent progress in the genetic characterisation of pleural mesothelioma, and...
-
Immunotherapy approaches for malignant pleural mesothelioma
Over the past decade, immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer. In mesothelioma, a rare cancer with a dismal...
-
An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration
IntroductionMalignant pleural mesothelioma (MPM) is an aggressive, treatment-resistant tumor. Anoikis is a particular type of programmed apoptosis...
-
A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) — a randomised feasibility study using the trial within a cohort (TwiC) methodology
BackgroundMalignant pleural mesothelioma (MPM) is an aggressive thoracic malignancy with a poor prognosis. Systemic immunotherapy is an effective...
-
Can ultrasound shear wave elastography differentiate between malignant and benign pleural effusions?
BackgroundMalignant pleural effusion is a common and unfortunately serious condition that is related to life poor quality and mortality. The majority...
-
Caregivers of patients with malignant pleural mesothelioma: who provides care, what care do they provide and what burden do they experience?
PurposeThere are limited data on the impact of caregiving for patients with malignant pleural mesothelioma (MPM) on the caregiver. We aimed to...
